These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22129228)

  • 1. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2012 Jan; 35(2):209-21. PubMed ID: 22129228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
    Gisbert JP; Castro-Fernandez M; Perez-Aisa A; Cosme A; Molina-Infante J; Rodrigo L; Modolell I; Cabriada JL; Gisbert JL; Lamas E; Marcos E; Calvet X
    Aliment Pharmacol Ther; 2012 Apr; 35(8):941-7. PubMed ID: 22372560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Gisbert JL; Marcos S; Pajares JM
    Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments.
    González Carro P; Pérez Roldán F; De Pedro Esteban A; Legaz Huidobro ML; Soto Fernández S; Roncero Garcia Escribano O; Esteban López-Jamar JM; Pedraza Martin C; Ruíz Carrillo F
    J Gastroenterol Hepatol; 2007 Jan; 22(1):60-3. PubMed ID: 17201882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
    Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
    BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
    Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L
    Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.
    Cammarota G; Martino A; Pirozzi G; Cianci R; Branca G; Nista EC; Cazzato A; Cannizzaro O; Miele L; Grieco A; Gasbarrini A; Gasbarrini G
    Aliment Pharmacol Ther; 2004 Apr; 19(7):789-95. PubMed ID: 15043520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifabutin for the Treatment of
    Gisbert JP
    Pathogens; 2020 Dec; 10(1):. PubMed ID: 33379336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
    Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Helicobacter pylori: recent advances in treatment.
    McLoughlin RM; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2005 Aug; 19(4):421-7. PubMed ID: 16011728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Pajares JM
    Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy.
    Gisbert JP; Pajares JM
    Rev Esp Enferm Dig; 2003 Mar; 95(3):220-8, 210-19. PubMed ID: 12760711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.